Associate Clinical Professor of Medicine, University Colorado
Hematology
Dr. Jeffrey V. Matous, MD
|
|
Give Review
Jeffrey V. Matous is an expert in the field of Hematology. He researched medicine at University of Washington School of Medicine. Jeffrey Matous is also a published doctor. He has 20 publication published. The most recent publication is: Structure-function relationships of stem cell factor: an analysis based on a series of human-murine stem cell factor chimera and the mapping of a neutralizing monoclon... Jeffrey Matous accepts Medicare payments and is listed with Medicare.gov.
Publications
- Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies.
- Active Idiotypic Vaccination Versus Control Immunotherapy for Follicular Lymphoma.
- Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy.
- Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study.
- A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma.
- Results of the phase II trial of single agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia.
- Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study.
- Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamide.
- Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared wit...
- Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.
- Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenstrom macroglobulinemia.
- A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma.
- Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma.
- Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.
- Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.
- Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248.
- A phase I/II study of arsenic trioxide/bortezomib/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma.
- Structure-function relationships of stem cell factor: an analysis based on a series of human-murine stem cell factor chimera and the mapping of a neutralizing monoclon...
- Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and muri...
Schools
University Of Washington School Of Medicine
University Of Colorado
University Of Colorado Health Sciences Center
University Of Washington Medical Center
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Stem Cell Transplant
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
University of Washington -
University of Colorado -
University of Washington School of Medicine
Drug Facts
| NPI NUMBER | 1992789036 | |
| NPPES Provider LastName | MATOUS | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 802181238 | |
| NPPES Provider State | CO | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 579.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 39.0 | |
| Percent Opioid Claims | 6.74 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1992789036 |
| Last Name Of The Provider | MATOUS |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
Dr. Tara K. Gregory, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Meghan S. Liel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew Eadens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan M. Freeman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter A. McSweeney, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Martin J. Rubinowitz, MD
This Doctor is OpenDoctor Recommended.
|